COVID-19 patients on the antiviral remdesivir recovered more than 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday as a top US scientist hailed the drug's "clear-cut" benefit.
from https://ift.tt/3d0CHA5
Sem comentários:
Enviar um comentário